Tisi, Maria Chiara
 Distribuzione geografica
Continente #
NA - Nord America 2.397
EU - Europa 1.586
AS - Asia 1.149
SA - Sud America 176
Continente sconosciuto - Info sul continente non disponibili 59
AF - Africa 38
OC - Oceania 3
Totale 5.408
Nazione #
US - Stati Uniti d'America 2.328
DE - Germania 614
SG - Singapore 429
CN - Cina 353
IT - Italia 166
SE - Svezia 165
PL - Polonia 164
BR - Brasile 135
VN - Vietnam 123
FR - Francia 114
GB - Regno Unito 108
UA - Ucraina 75
IN - India 64
IE - Irlanda 39
FI - Finlandia 37
RU - Federazione Russa 37
ID - Indonesia 29
TR - Turchia 29
CA - Canada 25
BD - Bangladesh 21
JP - Giappone 18
IL - Israele 16
BE - Belgio 13
MX - Messico 13
NL - Olanda 10
AR - Argentina 9
PK - Pakistan 9
CI - Costa d'Avorio 8
EC - Ecuador 8
HK - Hong Kong 8
IQ - Iraq 8
LT - Lituania 8
SA - Arabia Saudita 8
VE - Venezuela 8
AT - Austria 7
ES - Italia 7
SC - Seychelles 7
ZA - Sudafrica 7
IR - Iran 6
CO - Colombia 5
GT - Guatemala 5
JM - Giamaica 5
SV - El Salvador 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
EG - Egitto 4
PE - Perù 4
TT - Trinidad e Tobago 4
UZ - Uzbekistan 4
AL - Albania 3
JO - Giordania 3
MA - Marocco 3
MY - Malesia 3
PH - Filippine 3
PR - Porto Rico 3
RO - Romania 3
TN - Tunisia 3
CG - Congo 2
CL - Cile 2
CR - Costa Rica 2
DK - Danimarca 2
ET - Etiopia 2
KZ - Kazakistan 2
NI - Nicaragua 2
NP - Nepal 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
GR - Grecia 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MQ - Martinica 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PW - Palau 1
RS - Serbia 1
Totale 5.349
Città #
Singapore 255
Chandler 251
Ashburn 236
Warsaw 159
San Jose 141
Fairfield 80
Beijing 75
Jacksonville 74
New York 68
Ann Arbor 65
Nanjing 56
Woodbridge 49
Nürnberg 48
Dearborn 47
Los Angeles 42
San Mateo 41
Hanoi 40
Dublin 39
Munich 39
Wilmington 39
Seattle 36
Houston 35
Frankfurt am Main 33
Ho Chi Minh City 31
Cattolica 30
Council Bluffs 29
Jakarta 26
Chicago 24
Milan 24
Rome 24
Dallas 23
Lauterbourg 23
The Dalles 22
Bremen 17
Helsinki 17
Lancaster 17
Nanchang 17
Hefei 16
Tokyo 16
Boston 15
Kunming 15
London 15
Lawrence 14
Santa Clara 14
Atlanta 13
Cambridge 13
Marseille 13
Moscow 13
Brussels 12
Phoenix 12
Redmond 12
North Bergen 11
Redwood City 11
São Paulo 11
Fremont 10
Princeton 10
Tianjin 10
Hyderabad 9
Jiaxing 9
Abidjan 8
Brooklyn 8
Elk Grove Village 8
Guangzhou 8
Hangzhou 8
Hong Kong 8
Izmir 8
Salt Lake City 8
Tampa 8
Boardman 7
Buffalo 7
Changsha 7
Norwalk 7
Orem 7
Shanghai 7
Amsterdam 6
Chengdu 6
Istanbul 6
Montreal 6
Mumbai 6
Shenyang 6
Tukwila 6
Alghero 5
Auburn Hills 5
Belo Horizonte 5
Da Nang 5
Denver 5
Düsseldorf 5
Haiphong 5
Hebei 5
Jeddah 5
Jinan 5
Johannesburg 5
Las Vegas 5
Poplar 5
University Park 5
Zhengzhou 5
Amelia 4
Kocaeli 4
Leawood 4
Mexico City 4
Totale 2.793
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 464
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 363
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 358
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 323
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 296
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 253
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 240
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. 210
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 203
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 198
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 192
A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas 189
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 174
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication. 168
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 166
FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET) 165
Intravascular large-B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative. 163
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 157
Small lymphocytic lymphoma in a patient with Fabry disease 153
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 152
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations 146
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 129
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study 120
Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study 120
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death 113
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report 110
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study 46
Brexucabtagene autoleucel in-vivo expansion and BTKi refractoriness have a negative influence on progression-free survival in mantle cell lymphoma: Results from CART-SIE study 37
Totale 5.408
Categoria #
all - tutte 17.839
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.839


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022207 0 0 0 0 25 5 12 43 14 17 41 50
2022/2023604 72 83 45 120 28 84 28 51 73 5 9 6
2023/2024236 11 81 4 5 9 43 2 28 1 0 27 25
2024/2025479 16 24 46 26 52 11 27 12 57 43 94 71
2025/20261.303 184 34 103 113 248 88 246 56 91 85 32 23
2026/2027711 94 198 140 241 38 0 0 0 0 0 0 0
Totale 5.408